Avasopasem manganese

N/A

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAvasopasem manganese
Drug Alias NameAvasopasemSC-72325AM-40419KM-4419GC-4419
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase stimulantsantioxidant
TargetsSuperoxide dismutase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Metastatic breast cancerOropharyngeal Squamous Cell Carcinoma (OPSCC) +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[10
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesGalera Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerStomatitis
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Oropharyngeal Squamous Cell Carcinoma (OPSCC)Oral Squamous Cell Carcinoma +[8

Other Information

ATC CodeN/A
Related LinksN/A